Skip to main content
. 2021 Mar 1;93(5):3165–3175. doi: 10.1002/jmv.26876

Figure 3.

Figure 3

Risk for disease severity in patients with SARS‐CoV‐2 RNAemia versus patients without detectable SARS‐CoV‐2 RNA. Each box represents the OR point estimate, and its area is proportional to the weight of the individual study. OR, odds ratio; SARS‐CoV‐2 RNAemia, severe acute respiratory syndrome coronavirus 2 RNA